Selective Binding of Antiinfluenza Drugs and Their Analogues to 'Open' and 'Closed' Conformations of H5N1 Neuraminidase

被引:16
|
作者
Wang, Pei [3 ]
Zhang, John Z. H. [1 ,2 ,3 ]
机构
[1] E China Normal Univ, Inst Theoret & Computat Sci, Shanghai 200062, Peoples R China
[2] E China Normal Univ, State Key Lab Precis Spectroscopy, Dept Phys, Shanghai 200062, Peoples R China
[3] New York Univ, Dept Chem, New York, NY 10003 USA
来源
JOURNAL OF PHYSICAL CHEMISTRY B | 2010年 / 114卷 / 40期
关键词
MOLECULAR-DYNAMICS; FREE-ENERGIES; CONTINUUM SOLVENT; MM-PBSA; INHIBITORS; PREDICTION; EFFICIENT; DOCKING; DESIGN;
D O I
10.1021/jp1030224
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
It was suggested that the open conformation of the 150-loop of H5N1 I avian influenza neuraminidase is intrinsically lower in energy than the closed conformation and that oseltamivir (tamiflu) favors binding to the closed conformation through a relatively slow conformational change [Russell, R. J. Nature 2006, 443, 45-491. In the present work, a systematic computational study is performed to investigate the binding mechanism of five ligands to H5N1 neurarninidase (H5N1 NA) with the 150-loop in both open and closed conformations through molecular docking, molecular dynamics simulations, and MM/PBSA free energy calculation. Our result shows that the electrostatic interactions between polar groups on the 150-loop and the charged groups of the ligands play a key role on the binding selectivity. In particular, ligands having a small positively charged group favor binding to the closed conformation of H5N1 I NA, while those having a large positively charged group generally prefer binding to the open conformation. Our analysis suggests that it may be possible to design new inhibitors with large basic groups that are selective for the open conformation and thereby have stronger binding affinity to H5N1 I neuraminidase.
引用
收藏
页码:12958 / 12964
页数:7
相关论文
共 50 条
  • [41] Docking study on chlorogenic acid as a potential H5N1 influenza A virus neuraminidase inhibitor
    Hua-Jun Luo
    Jun-Zhi Wang
    Jian-Feng Chen
    Kun Zou
    Medicinal Chemistry Research, 2011, 20 : 554 - 557
  • [42] The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
    Rupert J. Russell
    Lesley F. Haire
    David J. Stevens
    Patrick J. Collins
    Yi Pu Lin
    G. Michael Blackburn
    Alan J. Hay
    Steven J. Gamblin
    John J. Skehel
    Nature, 2006, 443 : 45 - 49
  • [43] A study on catalytic and non-catalytic sites of H5N1 and H1N1 neuraminidase as the target for chalcone inhibitors
    Pandu Hariyono
    Jasvidianto Chriza Kotta
    Christophorus Fideluno Adhipandito
    Eko Aprilianto
    Evan Julian Candaya
    Habibah A. Wahab
    Maywan Hariono
    Applied Biological Chemistry, 2021, 64
  • [44] In silico screening of herbal and nanoparticle lead compounds for effectivity against H5N1, H1N1 neuraminidase and telomerase
    Sayak Ganguli
    Manjita Mazumder
    Protip Basu
    Paushali Roy
    Sayani Mitra
    Abhijit Datta
    BMC Bioinformatics, 11
  • [45] A study on catalytic and non-catalytic sites of H5N1 and H1N1 neuraminidase as the target for chalcone inhibitors
    Hariyono, Pandu
    Kotta, Jasvidianto Chriza
    Adhipandito, Christophorus Fideluno
    Aprilianto, Eko
    Candaya, Evan Julian
    Wahab, Habibah A.
    Hariono, Maywan
    APPLIED BIOLOGICAL CHEMISTRY, 2021, 64 (01)
  • [46] Graphical representation and numerical characterization of H5N1 avian flu neuraminidase gene sequence
    Nandy, Ashesh
    Basak, Subhash C.
    Gute, Brian D.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (03) : 945 - 951
  • [47] Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza A viruses
    Scheibner, David
    Salaheldin, Ahmed H.
    Bagato, Ola
    Zaeck, Luca M.
    Mostafa, Ahmed
    Blohm, Ulrike
    Mueller, Christin
    Eweas, Ahmed F.
    Franzke, Kati
    Karger, Axel
    Schaefer, Alexander
    Gischke, Marcel
    Hoffmann, Donata
    Lerolle, Solene
    Li, Xuguang
    Abd El-Hamid, Hatem S.
    Veits, Jutta
    Breithaupt, Angele
    Boons, Geert-Jan
    Matrosovich, Mikhail
    Finke, Stefan
    Pleschka, Stephan
    Mettenleiter, Thomas C.
    de Vries, Robert P.
    Abdelwhab, Elsayed M.
    PLOS PATHOGENS, 2023, 19 (02)
  • [48] Designing Cyclopentapeptide Inhibitor of Neuraminidase H5N1 Virus Through Molecular and Pharmacology Simulations
    Tambunan, Usman Sumo Friend
    Parikesit, Arli Aditya
    Unadi, Yossy Carolina
    Kerami, Djati
    TSINGHUA SCIENCE AND TECHNOLOGY, 2015, 20 (05) : 431 - 440
  • [49] Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus
    Shu, Mao
    Lin, Zhihua
    Zhang, Yunru
    Wu, Yuqian
    Mei, Hu
    Jiang, Yongjun
    JOURNAL OF MOLECULAR MODELING, 2011, 17 (03) : 587 - 592
  • [50] The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
    Russell, Rupert J.
    Haire, Lesley F.
    Stevens, David J.
    Collins, Patrick J.
    Lin, Yi Pu
    Blackburn, G. Michael
    Hay, Alan J.
    Gamblin, Steven J.
    Skehel, John J.
    NATURE, 2006, 443 (7107) : 45 - 49